Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin

A triple therapy based on a proton pump inhibitor (PPI), amoxicillin (AMPC), and clarithromycin (CAM) is recommended as a first-line therapy for Helicobacter pylori (H. pylori) eradication and is widely used in Japan. However, a decline in eradication rate associated with an increase in prevalence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Makoto, Ogasawara, Naotaka, Utsumi, Keiko, Kawamura, Naohiko, Kamiya, Tskeshi, Kataoka, Hiromi, Tanida, Satoshi, Mizoshita, Tsutomu, Kasugai, Kunio, Joh, Takashi
Formato: Texto
Lenguaje:English
Publicado: the Society for Free Radical Research Japan 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901764/
https://www.ncbi.nlm.nih.gov/pubmed/20664731
http://dx.doi.org/10.3164/jcbn.10-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901764/
https://www.ncbi.nlm.nih.gov/pubmed/20664731
http://dx.doi.org/10.3164/jcbn.10-10

Ejemplares similares